The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Zilver PTX Trial Shows Benefits of DES in Treating SFA Disease

September 24, 2010—Principal investigator Michael D. Dake, MD, presented 1-year results from an evaluation of the Zilver PTX paclitaxel-eluting stent (Cook Medical, Blooming…

FlowCardia’s Crosser Studied in Peripheral CTO Treatment

September 22, 2010—In an analysis of the RESPECT registry, the Crosser chronic total occlusion (CTO) recanalization catheter system (FlowCardia, Inc., Sunnyvale, CA) demonst…

Embolic Capture Angioplasty

Robert S. Dieter, MD, RVT, and Aravinda Nanjundappa, MD, RVT, MBA

September 2010—A new device offers the same features as standard balloon angioplasty for lower extremity procedures but with the addition of debris capture and removal.

US Enrollment Begins in OSPREY Study of Terumo’s Misago SFA Stent

September 13, 2010—Terumo Interventional Systems (Somerset, NJ) announced the first United States patient implant in the OSPREY (Occlusive/Stenotic Peripheral Artery Revascu…

Percutaneous Endovascular Repair of a Distal SFA Aneurysm

Sotero E. Peralta, MD; Julio Calderin, MD; and Toufic K. Safa, MD, FACS

August 2010—This technique offers a relatively simple solution to a rare clinical presentation.

Medtronic Concludes Enrollment in Clinical Study of Complete SE Vascular Stent

August 6, 2010—Medtronic, Inc. (Minneapolis, MN) announced that it has completed enrollment in a clinical trial of the company’s Complete SE self-expanding vascular stent …

Perspectives on RESILIENT

July 2010—John R. Laird Jr, MD, and Barry T. Katzen, MD, the principal investigators of the recently published RESILIENT trial, discuss the current SFA study landscape and explain that although angioplasty alone may be sufficient for short lesions, these data show that there is a place for stenting in this challenging vessel.

CE Mark Approval Received for 25-cm Gore Viabahn to Treat SFA

July 1, 2010—W. L. Gore & Associates (Flagstaff, AZ) announced that it has received CE Mark approval for the 25-cm Gore Viabahn endoprosthesis with Propaten bioactive su…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.